亚日韩在线中文字幕亚洲,国产在线播放鲁啊鲁视频,张柏芝手扒性器全部图片,亚洲成无码电影在线观看

首頁>細胞CELL>ATCC普通細胞>MAT-Ly-Lu-B-2 [MLLB-2]
MAT-Ly-Lu-B-2 [MLLB-2]
    MAT-Ly-Lu-B-2 [MLLB-2]
  • 平臺編號:bio-68149
  • 國際編號:ATCC CRL-2376
  • 細胞信息: MAT-Ly-Lu-B-2 [MLLB-2]
  • 規(guī)格:frozen
  • 用途:ATCC原裝細胞
  • 服務費用:
    加載中……
  • 訂購
  • 注意事項:僅用于科學研究或者工業(yè)應用等非醫(yī)療目的不可用于人類或動物的臨床診斷或治療,非藥用,非食用(產品信息以出庫為準)

數量:大量
是否是腫瘤細胞:0
物種來源:褐鼠
細胞形態(tài):上皮樣
品系:Copenhagen
年限:22 months
生長狀態(tài):貼壁生長
ATCC Number:CRL-2376?
運輸方式:凍存運輸
相關疾?。浩渌膊?br /> 器官來源:前列腺
規(guī)格:0.1ml Designations: MAT-Ly-Lu-B-2 [MLLB-2]
Depositors: ?KJ Pienta
Biosafety Level:1
Shipped: frozen
Medium & Serum: See Propagation Growth Properties:adherent
Organism: Rattus norvegicus deposited as rat
Morphology:epithelial


Source: Organ: prostate
Strain: Copenhagen
Disease: malignant carcinoma
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: 22 months
Gender: male
Comments:MAT-Ly-Lu-B-2 was developed from the MAT-LyLu cell line (ATCC JHU-92). MAT-LyLu was derived from a adult malignant rat prostate tumor obtained from a 22 month old inbred Copenhagen rat by Isaacs et al. [39920 ]
The parental cells were grown in increasing concentrations of the drug doxorubicin until the final concentration of 0.001 mM was achieved.
These cells express a multidrug (MDR) resistant phenotype. They are more resistant to vinblastine compared to controls. [39921 ]
This cell line can be used to study chemotherapy resistance in prostate cancer.
Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 0.001 mM doxorubicin, 90%; fetal bovine serum, 10%
Temperature: 37.0℃
Subculturing: Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended
Medium Renewal: Every 2 to 3 days
Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37C) until the cells detach.
Add fresh culture medium, aspirate and dispense into new culture flasks.
Preservation: culture medium 95%; DMSO, 5%
Related Products:Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
parent:ATCC JHU-92
References: 39920: Isaacs JT, et al. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 9: 261-281, 1986. PubMed: 3774632
39921: Replogle-Schwab TS, et al. Development of doxorubicin resistant rat prostate cancer cell lines. Anticancer Res. 17: 4535-4538, 1997. PubMed: 9494564

临汾市| 教育| 西吉县| 舟山市| 吉林市| 昆明市| 西乌珠穆沁旗| 浮山县| 洪江市| 尚义县| 信阳市| 库尔勒市| 稷山县| 平远县| 合阳县| 浦北县| 玉田县| 文成县| 沅江市| 萨嘎县| 大埔区| 滦平县| 府谷县| 荥经县| 宿迁市| 长岭县| 祥云县| 宁远县| 江阴市| 江油市| 永嘉县| 水富县| 厦门市| 汽车| 塔河县| 定安县| 富蕴县| 原平市| 邳州市| 沾化县| 白朗县|